TuttoCongressi
E-mail
Password
Resta Collegato

Cerca per parole nell'archivio:


In archivio:
  • N° Relazioni: 478
  • N° Accessi Relaz.: 168937
Web Video
Portale Giovani Medici

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali Live Demo

   Mostra tutti | Mostra contenuti EasyRec   
ABCDEFGHIJKLMNOPQRSTUVWXYZ
A
A. George Awad 
Subjective Tolerability to Antipsychotics in Schizophrenia, Over 30 Years of Research: Are We on the Verge of a New Science of "Subjective Tolerability Disorders"
Akira Sawa 
Moving from gene to function in mutant model of schizophrenia
Alain Dagher 
The Role of Environmental Factors
Alessandro Bertolino 
.
Alessandro Guidotti 
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon
Alessandro Serretti 
Methods for obtaining clinically useful pharmacogenetic predictors; An example of a detailed investigation in an haloperidol treated sample
Alex Hofer 
Social Cognition
Amanda Law 
ErbB4 and PI3KCD and are Interacting Biological and Genetic Factors That Regulate NRG1-mediated PI3K Signaling and Risk for Schizophrenia.
Andreas Meyer-Lindenberg 
Andreas Meyer-Lindenberg 
Mechanisms of GEI in schizophrenia
Andrew Thompson 
Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodromal Longitudinal Study
Anil Malhotra 
Pharmacogenomic approaches to rare and common side effects associated with antipsychotic drug treatment
Anissa Abi-Dargham 
Linking dopamine dysregulation to symptoms and clinical phase brain imaging studies
Anthony Grace 
The neurodevelopmental perspective: Dopamine system overdrive by the hippocampus in an animal model of schizophrenia and reversal by antipsychotic drugs
Assembly of the Associates 
Assembly of the Associates
 

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali

Tuttocongressi ©1995 - 2026 | Via Dei Perfetti Ricasoli, 94-96 - 50127 Firenze  |  P.Iva 03755090481